Brain Mapping (qEEG) Assessment

A 90-minute EEG-based assessment that maps the brain's electrical activity across multiple regions to evaluate neurological function. Includes electrode data collection, a detailed written report, and a 30-minute online consultation with the clinic's brain specialist.

Brain mapping — also known as quantitative EEG (qEEG) — is the process of recording and analysing the brain's electrical activity to produce a detailed map of neurological function. At New Leaf, this assessment is conducted by Santiago Brand, the clinic's brain specialist, and serves as the diagnostic foundation for personalised neurofeedback and brain training protocols. The 90-minute session begins with the placement of EEG electrodes across the scalp to record brainwave patterns in real time. The system captures activity across multiple brain regions simultaneously, generating a rich dataset of delta, theta, alpha, beta, and gamma wave amplitudes and frequencies. This data is then processed into a visual brain map that highlights areas of over- or under-activation, asymmetries, and connectivity patterns that may be linked to conditions such as anxiety, ADHD, depression, cognitive fatigue, poor sleep, or post-concussion symptoms. Following the assessment, New Leaf prepares a comprehensive written report of findings, which is delivered via email. Clients are then invited to a 30-minute online consultation with Santiago Brand to walk through the results, understand what the patterns mean for their specific concerns, and discuss recommended next steps — which may include neurofeedback therapy, lifestyle adjustments, or integration with counselling or nutrition services at the clinic. The brain mapping assessment is particularly relevant for individuals struggling with persistent mental health symptoms that have not responded well to talk therapy alone, those interested in optimising cognitive performance, and clients who want objective, data-driven insight into how their brain is functioning rather than relying solely on self-reported symptoms.